XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B (KrASIA)
KrASIA: XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B — The company provides its AI technology to pharmaceutical...
